SEC Form 4 · accession 0001171843-15-003709
TETRALOGIC PHARMACEUTICALS Corp · TLOG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul J Schmitt
Director
Period of report
Jul 2, 2015
Accepted (ET)
Jul 6, 2015 · 2:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001361248
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 2, 2015 | P | 3,500 | $2.334 | A | 13,500 | I | See footnote |
| Common StockF1 | Jul 2, 2015 | P | 6,500 | $2.3366 | A | 20,000 | I | See footnote |
| Common Stock | holding | — | — | — | 10,000 | D | ||
| Common StockF2 | holding | — | — | — | 1,512,962 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are held of record by the reporting person's spouse, Sharon Z. Schmitt. The reporting person does not have voting and investment power over the shares beneficially owned by Sharon Z. Schmitt, and disclaims beneficial ownership of the shares beneficially owned by Sharon Z. Schmitt.
- F2The securities are held of record by Novitas Capital III, LP. ("Novitas III"), Novitas Capital III GP, LP ("Novitas GP") and Novitas Capital III GP Manager, LLC ("Novitas Manager"). Novitas GP is the general partner of Novitas III and Novitas Manager is the general partner of Novitas GP. The reporting person, a partner in HVPIII and HVAIII, has voting and investment power over the shares beneficially owned by HVPIII and HVAIII, and disclaims beneficial ownership of the shares beneficially owned by Novitas III, Novitas GP and Novitas Manager, except to the extent of his pecuniary interest therein.